{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:29:19Z","timestamp":1787038159428,"version":"build-2736575974"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"name":"University of Minnesota Research Office"},{"name":"Division of Infectious Diseases and International Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Solid organ transplant recipients (SOTRs) exhibit suboptimal immune responses to standard-dose influenza vaccines. High-dose (HD) vaccines and booster strategies show promise, but the optimal vaccination approach for SOTRs remains undefined. We sought to evaluate a double vs a single HD influenza vaccine regimen, with the hypothesis that the double HD would yield superior immunogenicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This randomized clinical trial during the 2023\u20132024 and 2024\u20132025 influenza seasons compared the immunogenicity, clinical outcomes, and safety of 2 HD 1 month apart vs 1 HD influenza vaccines in 65 adult SOTRs at the University of Minnesota. The study comprised 3 visits: baseline, 1-month follow-up, and 4-month follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The primary analysis showed greater but no statistically significant geometric mean fold rises (GMFRs) of ID80 neutralizing and binding antibody titers from baseline to 4-month follow-up in the 2 HD group compared with the 1 HD group. However, exploratory analyses focusing on the period before to after the second injection (1\u20134 months) showed statistically significant differences in GMFRs for both ID80 neutralizing and binding titers of most strains when comparing the 2 groups. Two participants from the 1 HD group developed laboratory-confirmed influenza. Adverse event frequency was balanced between groups, with reactogenicity symptoms within 7 days of injection being grade 1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While a single HD vaccine provides an initial immune response, an HD booster appeared to improve overall immune responses to influenza strains contained in the vaccine formulation, although confirmation in larger, adequately powered studies is needed.<\/jats:p>\n                    <jats:p>Clinical Trials Registration. NCT05663463<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag494","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:51:24Z","timestamp":1785930684000},"source":"Crossref","is-referenced-by-count":0,"title":["A Randomized, Double-Blind Clinical Trial of One vs Two Doses of High-Dose Influenza Vaccine in Solid Organ Transplant Recipients"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-7486","authenticated-orcid":false,"given":"Kevin","family":"Escand\u00f3n","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7066-5075","authenticated-orcid":false,"given":"Sophia Q","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0134-2589","authenticated-orcid":false,"given":"Jamie","family":"Forschmiedt","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Health Data Science, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang","family":"Low","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-1406","authenticated-orcid":false,"given":"Bob C","family":"Lin","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8045-1754","authenticated-orcid":false,"given":"Mike","family":"Castro","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Narpala","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid A","family":"Serebryannyy","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Anderson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrett","family":"Reichel","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Koup","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle D","family":"Rudser","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Health Data Science, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3788-7763","authenticated-orcid":false,"given":"Hareesh","family":"Singam","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0480-9646","authenticated-orcid":false,"given":"Joshua","family":"Rhein","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kline","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-9937","authenticated-orcid":false,"given":"Timothy W","family":"Schacker","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6931-2198","authenticated-orcid":false,"given":"Lauren M","family":"Fontana","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2026081803220473100_ofag494-B1","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A 5-year prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026081803220473100_ofag494-B2","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"2026081803220473100_ofag494-B3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/lt.22283","article-title":"Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients","volume":"17","author":"Haller","year":"2011","journal-title":"Liver Transpl"},{"key":"2026081803220473100_ofag494-B4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw855","article-title":"Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial","volume":"64","author":"Cordero","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026081803220473100_ofag494-B5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cid\/ciad534","article-title":"The durability of antibody responses of two doses of high-dose relative to two doses of standard-dose inactivated influenza vaccine in pediatric hematopoietic cell transplant recipients: a multi-center randomized controlled trial","volume":"78","author":"Schuster","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026081803220473100_ofag494-B6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/cid\/ciad458","article-title":"Comparison of two high-dose versus two standard-dose influenza vaccines in adult allogeneic hematopoietic cell transplant recipients","volume":"77","author":"Thomas","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026081803220473100_ofag494-B7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older","volume":"200","author":"Falsey","year":"2009","journal-title":"J Infect Dis"},{"key":"2026081803220473100_ofag494-B8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"2026081803220473100_ofag494-B9","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026081803220473100_ofag494-B10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbmt.2015.12.003","article-title":"Randomized double-blind study of the safety and immunogenicity of standard-dose trivalent inactivated influenza vaccine versus high-dose trivalent inactivated influenza vaccine in adult hematopoietic stem cell transplantation patients","volume":"22","author":"Halasa","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026081803220473100_ofag494-B11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/petr.12419","article-title":"Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients","volume":"19","author":"GiaQuinta","year":"2015","journal-title":"Pediatr Transplant"},{"key":"2026081803220473100_ofag494-B12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pbc.24863","article-title":"Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia","volume":"61","author":"McManus","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2026081803220473100_ofag494-B13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.15585\/mmwr.mm7143a1","article-title":"Influenza incidence and vaccine effectiveness during the southern hemisphere influenza season\u2014Chile, 2022","volume":"71","author":"Olivares Barraza","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026081803220473100_ofag494-B14","author":"U.S. Food and Drug Administration"},{"key":"2026081803220473100_ofag494-B15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41467-021-21954-2","article-title":"A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies","volume":"12","author":"Creanga","year":"2021","journal-title":"Nat Commun"},{"key":"2026081803220473100_ofag494-B16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/jiz471","article-title":"Cell-mediated immune responses after influenza vaccination of solid organ transplant recipients: secondary outcomes analyses of a randomized controlled trial","volume":"221","author":"L'Huillier","year":"2020","journal-title":"J Infect Dis"},{"key":"2026081803220473100_ofag494-B17","doi-asserted-by":"crossref","first-page":"106538","DOI":"10.1016\/j.jinf.2025.106538","article-title":"High-dose versus standard-dose influenza vaccine for immunocompromised patients: a systematic review and meta-analysis of randomised clinical trials","volume":"91","author":"Rivera-Izquierdo","year":"2025","journal-title":"J Infect"},{"key":"2026081803220473100_ofag494-B18","author":"CDC"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag494\/70530893\/ofag494.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/8\/ofag494\/70530893\/ofag494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/8\/ofag494\/70530893\/ofag494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:22:08Z","timestamp":1787037728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag494\/8754106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag494","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8,1]]},"article-number":"ofag494"}}